Breaking News
Investing Pro 0
Cyber Monday Extended SALE: Up to 60% OFF InvestingPro+ CLAIM OFFER
Close

Abbott Laboratories (ABT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
101.00 0.00    0.00%
29/11 - Closed. Currency in CHF ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 93.00 / 108.00
  • Day's Range: 101.00 - 101.00
Type:  Equity
Market:  Switzerland
ISIN:  US0028241000 
VALOR:  903037
Abbott Labs 101.00 0.00 0.00%

ABT Balance Sheet

 
Assess the latest Abbott balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2022
30/09
2022
30/06
2022
31/03
2021
31/12
Total Current Assets 24845 24956 23429 24239
Cash and Short Term Investments 9907 9290 - -
Cash - - - -
Cash & Equivalents 9594 8937 7675 9799
Short Term Investments 313 353 483 450
Total Receivables, Net 6408 7199 7179 6487
Accounts Receivables - Trade, Net 6408 7199 7179 6487
Total Inventory 5734 5899 5691 5157
Prepaid Expenses 1888 2005 2048 2054
Other Current Assets, Total 908 563 353 292
Total Assets 72801 74202 74007 75196
Property/Plant/Equipment, Total - Net 8689 8818 8908 10112
Property/Plant/Equipment, Total - Gross 19306 19458 19521 20517
Accumulated Depreciation, Total -10617 -10640 -10613 -10405
Goodwill, Net 22284 22744 23179 23231
Intangibles, Net 10850 11592 12225 12739
Long Term Investments 479 431 406 512
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 5654 5661 5860 391
Other Assets, Total 547 -384 -652 3384
Total Current Liabilities 13365 12392 12647 13105
Accounts Payable 4133 4493 4757 4408
Payable/Accrued - - - -
Accrued Expenses 6694 6543 6448 6464
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 1117 5 4 999
Other Current liabilities, Total 1421 1351 1438 1234
Total Liabilities 36917 37486 38378 39172
Total Long Term Debt 15463 16836 17120 17296
Long Term Debt 15463 16836 17120 17296
Capital Lease Obligations - - - -
Deferred Income Tax - - - 1392
Minority Interest 209 226 230 222
Other Liabilities, Total 7467 7595 7890 6636
Total Equity 35884 36716 - -
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 24560 24429 24304 24470
Additional Paid-In Capital - - - -
Retained Earnings (Accumulated Deficit) 35115 34487 33295 31528
Treasury Stock - Common -14555 -13720 -13726 -11822
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -9236 -8480 -8244 -8152
Total Liabilities & Shareholders' Equity 72801 74202 74007 75196
Total Common Shares Outstanding 1743.57 1751.22 1750.94 1764.08
Total Preferred Shares Outstanding - - - -
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ABT Comments

Write your thoughts about Abbott Laboratories
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Babar Ali
Babar Ali Aug 27, 2020 18:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
trump sign 750 million deal with Abbott will go up??
Alexander Nygaard
Alexander Nygaard Aug 27, 2020 18:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
750M deal and the company is valued at 196B... use your brain
Mihai Barbulescu
Mihai Barbulescu Aug 27, 2020 18:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Yeah! It will go up a lot! Like 2%!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email